Article(id=1330184485691306144, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.07.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1676476800000, receivedDateStr=2023-02-16, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070295020, onlineDateStr=2026-11-19, pubDate=1688918400000, pubDateStr=2023-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070295020, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070295020, creator=13701087609, updateTime=1795070295020, updator=13701087609, issue=Issue{id=1330184417563226564, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='7', pageStart='983', pageEnd='1143', issueExtLink='null', onlineDate='null', pubDate='1688918400000', pubDateStr='2023-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070278778, creator='13701087609', updateTime=1795080510554, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227333488816580, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227333488816581, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=993, endPage=1001, ext={EN=ArticleExt(id=1330184485871661217, articleId=1330184485691306144, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress of Inhalation Preparations for Pulmonary Infectious Diseases, columnId=1330184420524405197, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Special Column on Frontier Technology for Drug Delivery, runingTitle=null, highlight=null, articleAbstract=

In recent years, pulmonary infectious diseases have posed a serious threat to human health. Compared with the traditional oral and injection administration routes, inhalation administration is increasingly used to treat pulmonary infectious diseases. This route can achieve targeted delivery of drugs to the infected sites, and has the advantages of improving the pulmonary bioavailability, reducing systemic adverse reactions and drug resistance, and therefore has gained widely concern. This paper summarizes the research progress of inhalation preparations for treatment of pulmonary infectious diseases, with a view to providing references for the research and development of anti-infective drugs for pulmonary inhalation.

, authors=Junyan GUO, Wenzhe WU, Jian WANG*, authorsList=Junyan GUO, Wenzhe WU, Jian WANG, authorCompany=null, correspAuthors=Jian WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184486085570722, articleId=1330184485691306144, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=吸入制剂用于肺部感染性疾病的研究进展, columnId=1330184420725731791, journalTitle=中国医药工业杂志, columnName=前沿递送技术专栏, runingTitle=null, highlight=null, articleAbstract=

近年来,肺部感染性疾病对人类的健康造成了严重威胁。相较于传统的口服和注射给药途径,吸入给药被越来越多地用于治疗肺部感染性疾病。该途径可靶向递送药物至感染部位,具有提高肺部生物利用度、减少全身不良反应和耐药性的优势,因而受到广泛关注。该文概述了用于肺部感染性疾病治疗的吸入制剂的研究进展,以期为肺部吸入用抗感染药物的研发提供参考。

, authors=郭俊彦, 吴闻哲, 王健*, authorsList=郭俊彦, 吴闻哲, 王健, authorCompany=null, correspAuthors=王健, authorNote=

郭俊彦(1999—),女,硕士研究生,专业方向:肺部吸入给药。

, correspAuthorsNote=
王健(1967—),男,研究员,博士生导师,从事黏膜给药制剂与新型吸入给药制剂研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=FFMzXz2QTqdeWRoRfk0jzw==, magXml=2KPbidyma4QEUuzscU3oCQ==, pdfUrl=null, pdf=qCAlYlcTUb5YpHmOzdiMMg==, pdfFileSize=1570536, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ZpFXo+fP/VozSRE11W1ACg==, mapNumber=null, fund=null)}, authors=[Author(id=1330184486324646055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184486379172009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486324646055, language=EN, stringName=Junyan GUO, firstName=Junyan, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184486437892266, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486324646055, language=CN, stringName=郭俊彦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio={"content":"

郭俊彦(1999—),女,硕士研究生,专业方向:肺部吸入给药。

"}, bioImg=null, bioContent=

郭俊彦(1999—),女,硕士研究生,专业方向:肺部吸入给药。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1330184486492418220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184486559527086, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486492418220, language=EN, stringName=Wenzhe WU, firstName=Wenzhe, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184486635024559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486492418220, language=CN, stringName=吴闻哲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1330184486693744817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wangjian11@sinopharm.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184486756659379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486693744817, language=EN, stringName=Jian WANG, firstName=Jian, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184486823768244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486693744817, language=CN, stringName=王健, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])])], keywords=[Keyword(id=1330184486920237237, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=EN, orderNo=1, keyword=inhalation preparation), Keyword(id=1330184486978957494, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=EN, orderNo=2, keyword=pulmonary infectious disease), Keyword(id=1330184487041872055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=EN, orderNo=3, keyword=inhalation vaccine), Keyword(id=1330184487096398008, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=EN, orderNo=4, keyword=inhaler device), Keyword(id=1330184487159312569, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=CN, orderNo=1, keyword=吸入制剂), Keyword(id=1330184487226421434, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=CN, orderNo=2, keyword=肺部感染性疾病), Keyword(id=1330184487285141691, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=CN, orderNo=3, keyword=吸入疫苗), Keyword(id=1330184487339667644, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, language=CN, orderNo=4, keyword=吸入装置)], refs=[Reference(id=1330184487419359421, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=赵小琳,宿怀予.关于抗菌药物雾化的几点思考[J].中国抗生素杂志,2021,46(7):653-660., articleTitle=null, refAbstract=null), Reference(id=1330184487486468286, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=LAXMINARAYAN R. The overlooked pandemic of antimicrobial resistance [J]. Lancet, 2022, 399(10325):606-607., articleTitle=null, refAbstract=null), Reference(id=1330184487545188543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=LUYT C E, CLAVEL M, GUNTUPALLI K, et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia [J]. Crit Care, 2009, 13(6): R200., articleTitle=null, refAbstract=null), Reference(id=1330184487616491712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=KONSTAN M W, WAGENER J S, PASTA D J, et al. Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis[J]. Pediatr Pulmonol, 2014, 49(6): 529-536., articleTitle=null, refAbstract=null), Reference(id=1330184487679406273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=EHSAN Z, CLANCY J. T100: nebulized-concentrated tobramycin formulation for treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients [J]. Expert Opin Orphan D, 2015, 3(8): 933-943., articleTitle=null, refAbstract=null), Reference(id=1330184487742320834, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SANDS D, SAPIEJKA E, MAZUREK H, et al. 69 A randomised comparison of VANTOBRA and TOBI in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection for pharmacokinetic and therapeutic equivalence[J]. J Cyst Fibros, 2013, 12(Suppl 1): S66., articleTitle=null, refAbstract=null), Reference(id=1330184487805235395, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO Y H, LU H W, MAO B, et al. The establishment of China Bronchiectasis Registry and Research Collaboration(BE-China): protocol of a prospective multicenter observational study [J]. Respir Res, 2022, 23(1): 328., articleTitle=null, refAbstract=null), Reference(id=1330184487876538564, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=GUAN W J, XU J F, LUO H, et al. A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection [J]. Chest, 2023,163(1): 64-76., articleTitle=null, refAbstract=null), Reference(id=1330184487964618949, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=FLUME P A, VAN DEVANTER D R. State of progress in treating cystic fibrosis respiratory disease [J]. BMC Med,2012, 10: 88., articleTitle=null, refAbstract=null), Reference(id=1330184488019144902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHUSTER A, HALIBURN C, DÖRING G, et al. Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study [J]. Thorax, 2013,68(4): 344-350., articleTitle=null, refAbstract=null), Reference(id=1330184488082059463, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHALMERS J D, VAN INGEN J, VAN DER LAAN R, et al. Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections [J]. Eur Respir Rev, 2021, 30(161): 210010., articleTitle=null, refAbstract=null), Reference(id=1330184488140779720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=WATERS V, RATJEN F. Inhaled liposomal amikacin [J]. Expert Rev Respir Med, 2014, 8(4): 401-409., articleTitle=null, refAbstract=null), Reference(id=1330184488216277193, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会呼吸病学分会感染学组.成人抗感染药物下呼吸道局部应用专家共识[J].中华结核和呼吸杂志,2021,44(4):322-339., articleTitle=null, refAbstract=null), Reference(id=1330184488304357578, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=张敏,张莉,陈树.两性霉素 B 雾化吸入治疗老年糖尿病患者下呼吸道真菌感染的临床观察[J].现代临床医学,2009,35(6):414-415., articleTitle=null, refAbstract=null), Reference(id=1330184488371466443, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=PATTERSON T F, THOMPSON G R 3rd, DENNING D W, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America [J]. Clin Infect Dis, 2016, 63(4): e1-e60., articleTitle=null, refAbstract=null), Reference(id=1330184488446963916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=DINESH KUMAR N, TER ELLEN B M, BOUMA E M, et al. Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary bronchial epithelial cells [J]. Antimicrob Agents Chemother,2022, 66(1): e0154321., articleTitle=null, refAbstract=null), Reference(id=1330184488522461389, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=KROLEWIECKI A, LIFSCHITZ A, MORAGAS M, et al. Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial [J]eClinicalMedicine, 2021, 37: 100959., articleTitle=null, refAbstract=null), Reference(id=1330184488597958862, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=MANSOUR S M, SHAMMA R N, AHMED K A, et al. Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: a preclinical tolerance study [J]. Int Immunopharmacol, 2021, 99: 108004., articleTitle=null, refAbstract=null), Reference(id=1330184488681844943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ALBARIQI A H, KE W R, KHANAL D, et al. Preparation and characterization of inhalable ivermectin powders as a potential COVID-19 therapy [J]. J Aerosol Med Pulm Drug Deliv, 2022, 35(5): 239-251., articleTitle=null, refAbstract=null), Reference(id=1330184488740565200, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=VELKOV T, ABDUL RAHIM N, ZHOU Q T, et al. Inhaled anti-infective chemotherapy for respiratory tract infections:successes, challenges and the road ahead [J]. Adv Drug Deliv Rev, 2015, 85: 65-82., articleTitle=null, refAbstract=null), Reference(id=1330184488803479761, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=AZOICAI D, ANTONIU S A. MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections [J]. Expert Opin Investig Drugs, 2013, 22(2): 267-276., articleTitle=null, refAbstract=null), Reference(id=1330184488858005714, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BALDUCCI A G, BETTINI R, COLOMBO P, et al. Drug delivery strategies for pulmonary administration of antibiotics[M]// NOKHODCHI A, MARTIN G P. Pulmonary drug delivery: advances and challenges. [s. l. ]: John Wiley &Sons Ltd. , 2015: 241-262., articleTitle=null, refAbstract=null), Reference(id=1330184488916725971, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CHADWICK H K, WHITE H, SHAW N, et al. Aztreonam lysine inhalation solution (AZLI, Cayston®, Gilead) stabilises lung function decline in patients with cystic fibrosis and moderate to severe lung disease [C]// Proceedings of the North American Cystic Fibrosis Conference. North American Cystic Fibrosis Conference. Denver: Colorado,2018., articleTitle=null, refAbstract=null), Reference(id=1330184488979640532, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=LANDA G, ALEJO T, SAUZET T, et al. Colistin-loaded aerosolizable particles for the treatment of bacterial respiratory infections [J]. Int J Pharm, 2023, 635:122732., articleTitle=null, refAbstract=null), Reference(id=1330184489034166485, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=高洁,张琪,吴闻哲.脂质体肺部吸入给药研究进展[J].中国医药工业杂志,2022,53(7):935-942., articleTitle=null, refAbstract=null), Reference(id=1330184489113858262, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=ONG H X, TRAINI D, YOUNG P. Liposomes for inhalation[M]// DHAND R, ROTHEN-RUTISHAUSER B, HICKEY A J. ISAM textbook of aerosol medicine. [s. l. ]: Mary Ann Liebert Inc. , 2015: 303-329., articleTitle=null, refAbstract=null), Reference(id=1330184489189355735, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=CARTLIDGE M K, HILL A T. Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis[J]. Expert Opin Investig Drugs, 2017, 26(9): 1091-1097., articleTitle=null, refAbstract=null), Reference(id=1330184489256464600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG J, LEIFER F, ROSE S, et al. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages [J]. Front Microbiol, 2018, 9: 915., articleTitle=null, refAbstract=null), Reference(id=1330184489327767769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=MEHTA P P, GHOSHAL D, PAWAR A P, et al. Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance [J]. J Drug Deliv Sci Technol, 2020, 56(Part A): 101509., articleTitle=null, refAbstract=null), Reference(id=1330184489382293722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=SIBUM I, HAGEDOORN P, DE BOER A H, et al. Challenges for pulmonary delivery of high powder doses[J]. Int J Pharm, 2018, 548(1): 325-336., articleTitle=null, refAbstract=null), Reference(id=1330184489445208283, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=PILCER G, WAUTHOZ N, AMIGHI K. Lactose characteristics and the generation of the aerosol [J]. Adv Drug Deliv Rev, 2012, 64(3): 233-256., articleTitle=null, refAbstract=null), Reference(id=1330184489503928540, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=郭娜,杨阳,王思玲,等.高效液相色谱法测定扎那米韦粉雾剂的含量及其体外有效部位沉积率[J].中国新药杂志,2013,22(4):408-410., articleTitle=null, refAbstract=null), Reference(id=1330184491106152669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=LEUNG S S Y, PARUMASIVAM T, TANG P, et al. A proof-of-principle setup for delivery of Relenza® (zanamivir) inhalation powder to intubated patients [J]. J Aerosol Med Pulm Drug Deliv, 2016, 29(1): 30-35., articleTitle=null, refAbstract=null), Reference(id=1330184491211010270, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN Y W, WONG J, QU L, et al. Powder production and particle engineering for dry powder inhaler formulations[J]. Curr Pharm Des, 2015, 21(27): 3902-3916., articleTitle=null, refAbstract=null), Reference(id=1330184491278119135, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=马银玲,刘红星,鲍亚然,等.吸入粉雾剂的喷雾工艺及表征研究进展[J].中国医院药学杂志,2021,41(13):1362-1365., articleTitle=null, refAbstract=null), Reference(id=1330184491349422304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=VANDEVANTER D R, GELLER D E. Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review [J]. Med Devices (Auckl), 2011, 4: 179-188., articleTitle=null, refAbstract=null), Reference(id=1330184491424919777, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=YU H, TEO J, CHEW J W, et al. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: spray drying versus spray freeze drying preparation [J]. Int J Pharm, 2016,499(1/2): 38-46., articleTitle=null, refAbstract=null), Reference(id=1330184491496222946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=VISHALI D A, MONISHA J, SIVAKAMASUNDARI S K, et al. Spray freeze drying: emerging applications in drug delivery [J]. J Control Release, 2019, 300: 93-101., articleTitle=null, refAbstract=null), Reference(id=1330184491567526115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=ABOULFOTOUH K, ZHANG Y, MANIRUZZAMAN M, et al. Amorphous solid dispersion dry powder for pulmonary drug delivery: advantages and challenges [J]. Int J Pharm,2020, 587: 119711., articleTitle=null, refAbstract=null), Reference(id=1330184491630440676, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU Q T, MORTON D A, YU H H, et al. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation [J]. J Pharm Sci, 2013, 102(10): 3736-3747., articleTitle=null, refAbstract=null), Reference(id=1330184491701743845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=CARPENTER D M, ROBERTS C A, SAGE A J, et al. A review of electronic devices to assess inhaler technique [J]. Curr Allergy Asthma Rep, 2017, 17(3): 17., articleTitle=null, refAbstract=null), Reference(id=1330184491764658406, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=O’TOOLE D P H, LATCHFORD G J, DUFF A J A, et al. Adherence to aerosol therapy in young people with cystic fibrosis: patient and parent perspectives following electronic data capture [J]. Qual Health Res, 2019, 29(6): 846-856., articleTitle=null, refAbstract=null), Reference(id=1330184491823378663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=葛华,蒋丽勇,刘术,等.经口途径COVID-19疫苗产品与技术分析[J].药学学报,2022,57(4):845-853., articleTitle=null, refAbstract=null), Reference(id=1330184491898876136, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=HASSAN A O, KAFAI N M, DMITRIEV I P, et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 [J]. Cell,2020, 183(1): 169-184., articleTitle=null, refAbstract=null), Reference(id=1330184491965985001, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=WU S, HUANG J, ZHANG Z, et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults:preliminary report of an open-label and randomised phase 1 clinical trial [J]. Lancet Infect Dis, 2021, 21(12): 1654-1664., articleTitle=null, refAbstract=null), Reference(id=1330184492041482474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=DAY T A, PENN-NICHOLSON A, LUABEYA A K K, et al. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial [J]. Lancet Respir Med,2021, 9(4): 373-386., articleTitle=null, refAbstract=null), Reference(id=1330184492129562859, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=SALEEM I, PETKAR K, SOMAVARAPU S. Chapter nineteen - rationale for pulmonary vaccine delivery: formulation and device considerations [M]//SKWARCZYNSKI M, TOTH I. Micro and nano technologies, micro and nanotechnology in vaccine development. [s. l. ]: Elsevier, 2017: 357-371., articleTitle=null, refAbstract=null), Reference(id=1330184492192477420, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=KANOJIA G, WILLEMS G J, FRIJLINK H W, et al. A design of experiment approach to predict product and process parameters for a spray dried influenza vaccine [J]. Int J Pharm, 2016, 511(2): 1098-1111., articleTitle=null, refAbstract=null), Reference(id=1330184492259586285, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=DE BOER A H, HAGEDOORN P, HOPPENTOCHT M, et al. Dry powder inhalation: past, present and future [J]. Expert Opin Drug Deliv, 2017, 14(4): 499-512., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.07.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.07.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.07.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.07.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1688918400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
吸入制剂用于肺部感染性疾病的研究进展
郭俊彦 , 吴闻哲 , 王健 *
中国医药工业杂志 | 前沿递送技术专栏 2023,54(7): 993-1001
收起
收藏切换
中国医药工业杂志 |前沿递送技术专栏 2023 , 54 (7) : 993 -1001
吸入制剂用于肺部感染性疾病的研究进展
全屏
[Author(id=1330184486324646055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184486379172009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486324646055, language=EN, stringName=Junyan GUO, firstName=Junyan, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184486437892266, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486324646055, language=CN, stringName=郭俊彦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio={"content":"

郭俊彦(1999—),女,硕士研究生,专业方向:肺部吸入给药。

"}, bioImg=null, bioContent=

郭俊彦(1999—),女,硕士研究生,专业方向:肺部吸入给药。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1330184486492418220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184486559527086, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486492418220, language=EN, stringName=Wenzhe WU, firstName=Wenzhe, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184486635024559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486492418220, language=CN, stringName=吴闻哲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1330184486693744817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wangjian11@sinopharm.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184486756659379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486693744817, language=EN, stringName=Jian WANG, firstName=Jian, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184486823768244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, authorId=1330184486693744817, language=CN, stringName=王健, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184486257537187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, xref=null, ext=[AuthorCompanyExt(id=1330184486261731492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1330184486270120101, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184485691306144, companyId=1330184486257537187, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])])]
郭俊彦, 吴闻哲, 王健*
作者信息
  • 中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203
通讯作者:
王健(1967—),男,研究员,博士生导师,从事黏膜给药制剂与新型吸入给药制剂研究。E-mail:
作者简介:

郭俊彦(1999—),女,硕士研究生,专业方向:肺部吸入给药。

Research Progress of Inhalation Preparations for Pulmonary Infectious Diseases
Junyan GUO, Wenzhe WU, Jian WANG*
Affiliations
  • National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2023-07-10 doi: 10.16522/j.cnki.cjph.2023.07.002
文章导航
收藏切换

近年来,肺部感染性疾病对人类的健康造成了严重威胁。相较于传统的口服和注射给药途径,吸入给药被越来越多地用于治疗肺部感染性疾病。该途径可靶向递送药物至感染部位,具有提高肺部生物利用度、减少全身不良反应和耐药性的优势,因而受到广泛关注。该文概述了用于肺部感染性疾病治疗的吸入制剂的研究进展,以期为肺部吸入用抗感染药物的研发提供参考。

吸入制剂  /  肺部感染性疾病  /  吸入疫苗  /  吸入装置

In recent years, pulmonary infectious diseases have posed a serious threat to human health. Compared with the traditional oral and injection administration routes, inhalation administration is increasingly used to treat pulmonary infectious diseases. This route can achieve targeted delivery of drugs to the infected sites, and has the advantages of improving the pulmonary bioavailability, reducing systemic adverse reactions and drug resistance, and therefore has gained widely concern. This paper summarizes the research progress of inhalation preparations for treatment of pulmonary infectious diseases, with a view to providing references for the research and development of anti-infective drugs for pulmonary inhalation.

inhalation preparation  /  pulmonary infectious disease  /  inhalation vaccine  /  inhaler device
郭俊彦, 吴闻哲, 王健. 吸入制剂用于肺部感染性疾病的研究进展. 中国医药工业杂志, 2023 , 54 (7) : 993 -1001 . DOI: 10.16522/j.cnki.cjph.2023.07.002
Junyan GUO, Wenzhe WU, Jian WANG. Research Progress of Inhalation Preparations for Pulmonary Infectious Diseases[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (7) : 993 -1001 . DOI: 10.16522/j.cnki.cjph.2023.07.002

参考文献 引证文献
排序方式:
[1]
赵小琳,宿怀予.关于抗菌药物雾化的几点思考[J].中国抗生素杂志,2021,46(7):653-660.
[2]
LAXMINARAYAN R. The overlooked pandemic of antimicrobial resistance [J]. Lancet, 2022, 399(10325):606-607.
[3]
LUYT C E, CLAVEL M, GUNTUPALLI K, et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia [J]. Crit Care, 2009, 13(6): R200.
[4]
KONSTAN M W, WAGENER J S, PASTA D J, et al. Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis[J]. Pediatr Pulmonol, 2014, 49(6): 529-536.
[5]
EHSAN Z, CLANCY J. T100: nebulized-concentrated tobramycin formulation for treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients [J]. Expert Opin Orphan D, 2015, 3(8): 933-943.
[6]
SANDS D, SAPIEJKA E, MAZUREK H, et al. 69 A randomised comparison of VANTOBRA and TOBI in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection for pharmacokinetic and therapeutic equivalence[J]. J Cyst Fibros, 2013, 12(Suppl 1): S66.
[7]
GAO Y H, LU H W, MAO B, et al. The establishment of China Bronchiectasis Registry and Research Collaboration(BE-China): protocol of a prospective multicenter observational study [J]. Respir Res, 2022, 23(1): 328.
[8]
GUAN W J, XU J F, LUO H, et al. A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection [J]. Chest, 2023,163(1): 64-76.
[9]
FLUME P A, VAN DEVANTER D R. State of progress in treating cystic fibrosis respiratory disease [J]. BMC Med,2012, 10: 88.
[10]
SCHUSTER A, HALIBURN C, DÖRING G, et al. Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study [J]. Thorax, 2013,68(4): 344-350.
[11]
CHALMERS J D, VAN INGEN J, VAN DER LAAN R, et al. Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections [J]. Eur Respir Rev, 2021, 30(161): 210010.
[12]
WATERS V, RATJEN F. Inhaled liposomal amikacin [J]. Expert Rev Respir Med, 2014, 8(4): 401-409.
[13]
中华医学会呼吸病学分会感染学组.成人抗感染药物下呼吸道局部应用专家共识[J].中华结核和呼吸杂志,2021,44(4):322-339.
[14]
张敏,张莉,陈树.两性霉素 B 雾化吸入治疗老年糖尿病患者下呼吸道真菌感染的临床观察[J].现代临床医学,2009,35(6):414-415.
[15]
PATTERSON T F, THOMPSON G R 3rd, DENNING D W, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America [J]. Clin Infect Dis, 2016, 63(4): e1-e60.
[16]
DINESH KUMAR N, TER ELLEN B M, BOUMA E M, et al. Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary bronchial epithelial cells [J]. Antimicrob Agents Chemother,2022, 66(1): e0154321.
[17]
KROLEWIECKI A, LIFSCHITZ A, MORAGAS M, et al. Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial [J]eClinicalMedicine, 2021, 37: 100959.
[18]
MANSOUR S M, SHAMMA R N, AHMED K A, et al. Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: a preclinical tolerance study [J]. Int Immunopharmacol, 2021, 99: 108004.
[19]
ALBARIQI A H, KE W R, KHANAL D, et al. Preparation and characterization of inhalable ivermectin powders as a potential COVID-19 therapy [J]. J Aerosol Med Pulm Drug Deliv, 2022, 35(5): 239-251.
[20]
VELKOV T, ABDUL RAHIM N, ZHOU Q T, et al. Inhaled anti-infective chemotherapy for respiratory tract infections:successes, challenges and the road ahead [J]. Adv Drug Deliv Rev, 2015, 85: 65-82.
[21]
AZOICAI D, ANTONIU S A. MP-376 (Aeroquin) for chronic Pseudomonas aeruginosa infections [J]. Expert Opin Investig Drugs, 2013, 22(2): 267-276.
[22]
BALDUCCI A G, BETTINI R, COLOMBO P, et al. Drug delivery strategies for pulmonary administration of antibiotics[M]// NOKHODCHI A, MARTIN G P. Pulmonary drug delivery: advances and challenges. [s. l. ]: John Wiley &Sons Ltd. , 2015: 241-262.
[23]
CHADWICK H K, WHITE H, SHAW N, et al. Aztreonam lysine inhalation solution (AZLI, Cayston®, Gilead) stabilises lung function decline in patients with cystic fibrosis and moderate to severe lung disease [C]// Proceedings of the North American Cystic Fibrosis Conference. North American Cystic Fibrosis Conference. Denver: Colorado,2018.
[24]
LANDA G, ALEJO T, SAUZET T, et al. Colistin-loaded aerosolizable particles for the treatment of bacterial respiratory infections [J]. Int J Pharm, 2023, 635:122732.
[25]
高洁,张琪,吴闻哲.脂质体肺部吸入给药研究进展[J].中国医药工业杂志,2022,53(7):935-942.
[26]
ONG H X, TRAINI D, YOUNG P. Liposomes for inhalation[M]// DHAND R, ROTHEN-RUTISHAUSER B, HICKEY A J. ISAM textbook of aerosol medicine. [s. l. ]: Mary Ann Liebert Inc. , 2015: 303-329.
[27]
CARTLIDGE M K, HILL A T. Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis[J]. Expert Opin Investig Drugs, 2017, 26(9): 1091-1097.
[28]
ZHANG J, LEIFER F, ROSE S, et al. Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages [J]. Front Microbiol, 2018, 9: 915.
[29]
MEHTA P P, GHOSHAL D, PAWAR A P, et al. Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance [J]. J Drug Deliv Sci Technol, 2020, 56(Part A): 101509.
[30]
SIBUM I, HAGEDOORN P, DE BOER A H, et al. Challenges for pulmonary delivery of high powder doses[J]. Int J Pharm, 2018, 548(1): 325-336.
[31]
PILCER G, WAUTHOZ N, AMIGHI K. Lactose characteristics and the generation of the aerosol [J]. Adv Drug Deliv Rev, 2012, 64(3): 233-256.
[32]
郭娜,杨阳,王思玲,等.高效液相色谱法测定扎那米韦粉雾剂的含量及其体外有效部位沉积率[J].中国新药杂志,2013,22(4):408-410.
[33]
LEUNG S S Y, PARUMASIVAM T, TANG P, et al. A proof-of-principle setup for delivery of Relenza® (zanamivir) inhalation powder to intubated patients [J]. J Aerosol Med Pulm Drug Deliv, 2016, 29(1): 30-35.
[34]
LIN Y W, WONG J, QU L, et al. Powder production and particle engineering for dry powder inhaler formulations[J]. Curr Pharm Des, 2015, 21(27): 3902-3916.
[35]
马银玲,刘红星,鲍亚然,等.吸入粉雾剂的喷雾工艺及表征研究进展[J].中国医院药学杂志,2021,41(13):1362-1365.
[36]
VANDEVANTER D R, GELLER D E. Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review [J]. Med Devices (Auckl), 2011, 4: 179-188.
[37]
YU H, TEO J, CHEW J W, et al. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: spray drying versus spray freeze drying preparation [J]. Int J Pharm, 2016,499(1/2): 38-46.
[38]
VISHALI D A, MONISHA J, SIVAKAMASUNDARI S K, et al. Spray freeze drying: emerging applications in drug delivery [J]. J Control Release, 2019, 300: 93-101.
[39]
ABOULFOTOUH K, ZHANG Y, MANIRUZZAMAN M, et al. Amorphous solid dispersion dry powder for pulmonary drug delivery: advantages and challenges [J]. Int J Pharm,2020, 587: 119711.
[40]
ZHOU Q T, MORTON D A, YU H H, et al. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation [J]. J Pharm Sci, 2013, 102(10): 3736-3747.
[41]
CARPENTER D M, ROBERTS C A, SAGE A J, et al. A review of electronic devices to assess inhaler technique [J]. Curr Allergy Asthma Rep, 2017, 17(3): 17.
[42]
O’TOOLE D P H, LATCHFORD G J, DUFF A J A, et al. Adherence to aerosol therapy in young people with cystic fibrosis: patient and parent perspectives following electronic data capture [J]. Qual Health Res, 2019, 29(6): 846-856.
[43]
葛华,蒋丽勇,刘术,等.经口途径COVID-19疫苗产品与技术分析[J].药学学报,2022,57(4):845-853.
[44]
HASSAN A O, KAFAI N M, DMITRIEV I P, et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 [J]. Cell,2020, 183(1): 169-184.
[45]
WU S, HUANG J, ZHANG Z, et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults:preliminary report of an open-label and randomised phase 1 clinical trial [J]. Lancet Infect Dis, 2021, 21(12): 1654-1664.
[46]
DAY T A, PENN-NICHOLSON A, LUABEYA A K K, et al. Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial [J]. Lancet Respir Med,2021, 9(4): 373-386.
[47]
SALEEM I, PETKAR K, SOMAVARAPU S. Chapter nineteen - rationale for pulmonary vaccine delivery: formulation and device considerations [M]//SKWARCZYNSKI M, TOTH I. Micro and nano technologies, micro and nanotechnology in vaccine development. [s. l. ]: Elsevier, 2017: 357-371.
[48]
KANOJIA G, WILLEMS G J, FRIJLINK H W, et al. A design of experiment approach to predict product and process parameters for a spray dried influenza vaccine [J]. Int J Pharm, 2016, 511(2): 1098-1111.
[49]
DE BOER A H, HAGEDOORN P, HOPPENTOCHT M, et al. Dry powder inhalation: past, present and future [J]. Expert Opin Drug Deliv, 2017, 14(4): 499-512.
2023年第54卷第7期
20
4
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.07.002
  • 接收时间:2023-02-16
  • 首发时间:2026-11-19
  • 出版时间:2023-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-02-16
基金
作者信息
    中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203

通讯作者:

王健(1967—),男,研究员,博士生导师,从事黏膜给药制剂与新型吸入给药制剂研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.07.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏